Georgia Tsaousi1, Barbara Fyntanidou2, George Stavrou3, Pyrros Papakostas4, Katerina Kotzampassi4, Vasilios Grosomanidis2. 1. Department of Anesthesiology and ICU, Faculty of Medicine, Aristotle University of Thessaloniki, University Campus, 54124, Thessaloniki, Greece. tsaousig@otenet.gr. 2. Department of Anesthesiology and ICU, Faculty of Medicine, Aristotle University of Thessaloniki, University Campus, 54124, Thessaloniki, Greece. 3. Department of General Surgery, York Teaching Hospital, NHS Foundation Trust, Wigginton Road, York, North Yorkshire, YO31 8HE, UK. 4. Department of Surgery, Faculty of Medicine, Aristotle University of Thessaloniki, University Campus, PO Box 54006, Thessaloniki, Greece.
Abstract
AIM: Sedation is considered as a prerequisite for the safe and effective conclusion of Bioenterics Intragastric Balloon (BIB) removal (our aim was to ascertain the most appropriate body size scalars for propofol dosing and assess the efficacy and safety of a sedative approach involving the infusion of propofol for BIB removal. METHOD: Retrospective analysis of prospectively collected data of 414 adults scheduled to undergo BIB removal. Our primary end-point was to delineate the relationship between propofol dosing and body size descriptors namely body mass index, total body weight, ideal body weight, lean body weight (LBW) and normalized LBW. Sedative efficacy of this practice, anesthesia or procedural-related adverse events and patients' satisfaction level served as secondary outcome parameters. RESULTS: Propofol dose (mg/kg/min) was positively related to all body weight descriptors in an important manner (p < 0.001). Among them, LBW was singled out as the body size descriptor to best capture the appropriate needs of propofol (R2 = 0.432; p = 0.000). Hypoxemia, hemodynamic compromise, gastroesophageal reflux or moderate movement occurred rarely; all of them were readily reversed. The majority of participants had no recollection of the noxious phase of the procedure or declared at least adequately satisfied from the experience (84% and 95%, respectively). CONCLUSION: LBW could serve as relatively more accurate dosing scalar compared to actual or ideal body weight descriptors, in obese individuals undergoing BIB removal under propofol sedation. The conscious/deep sedation based on propofol infusion emerges as a feasible and efficacious sedative approach for this procedure.
AIM: Sedation is considered as a prerequisite for the safe and effective conclusion of Bioenterics Intragastric Balloon (BIB) removal (our aim was to ascertain the most appropriate body size scalars for propofol dosing and assess the efficacy and safety of a sedative approach involving the infusion of propofol for BIB removal. METHOD: Retrospective analysis of prospectively collected data of 414 adults scheduled to undergo BIB removal. Our primary end-point was to delineate the relationship between propofol dosing and body size descriptors namely body mass index, total body weight, ideal body weight, lean body weight (LBW) and normalized LBW. Sedative efficacy of this practice, anesthesia or procedural-related adverse events and patients' satisfaction level served as secondary outcome parameters. RESULTS:Propofol dose (mg/kg/min) was positively related to all body weight descriptors in an important manner (p < 0.001). Among them, LBW was singled out as the body size descriptor to best capture the appropriate needs of propofol (R2 = 0.432; p = 0.000). Hypoxemia, hemodynamic compromise, gastroesophageal reflux or moderate movement occurred rarely; all of them were readily reversed. The majority of participants had no recollection of the noxious phase of the procedure or declared at least adequately satisfied from the experience (84% and 95%, respectively). CONCLUSION: LBW could serve as relatively more accurate dosing scalar compared to actual or ideal body weight descriptors, in obese individuals undergoing BIB removal under propofol sedation. The conscious/deep sedation based on propofol infusion emerges as a feasible and efficacious sedative approach for this procedure.
Entities:
Keywords:
Body weight scalar; Intragastric balloon; Obesity; Propofol
Authors: Douglas J Eleveld; Johannes H Proost; Hugo Vereecke; Anthony R Absalom; Erik Olofsen; Jaap Vuyk; Michel M R F Struys Journal: Anesthesiology Date: 2017-06 Impact factor: 7.892
Authors: Patricia D Scherrer; Michael D Mallory; Joseph P Cravero; Lia Lowrie; James H Hertzog; John W Berkenbosch Journal: Paediatr Anaesth Date: 2015-03-27 Impact factor: 2.556
Authors: T Sasaki; S Tanabe; M Azuma; A Sato; A Naruke; K Ishido; C Katada; K Higuchi; W Koizumi Journal: Endoscopy Date: 2012-05-25 Impact factor: 10.093
Authors: Yanhong Liu; May C M Pian-Smith; Lisa R Leffert; Rebecca D Minehart; Andrea Torri; Charles Coté; Robert M Kacmarek; Yandong Jiang Journal: J Clin Monit Comput Date: 2014-12-16 Impact factor: 2.502